EP Patent

EP2399513B1 — System for non-invasive automated monitoring, detection, analysis, characterisation, prediction or prevention of seizures and movement disorder symptoms

Assigned to Qatar University Qstp-B · Expires 2017-01-04 · 9y expired

What this patent protects

Patent listed against fenfluramine-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
EP2399513B1
Jurisdiction
EP
Classification
—
Expires
2017-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Qatar University Qstp-B
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.